Update on vaccine-derived polioviruses — Worldwide, July 2012–December 2013

Morbidity and Mortality Weekly Report

Volumn , Issue 11, 2014, Pages 242-248

  Diop, Ousmane M ^a   Burns, Cara C ^b   Wassilak, Steven G ^c   Kew, Olen M ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b Global Polio Laboratory Network   (Switzerland)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; ORAL POLIOMYELITIS VACCINE;

ARTICLE; CLASSIFICATION; FEMALE; HEALTH; HUMAN; INFANT; ISOLATION AND PURIFICATION; MALE; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRESCHOOL CHILD; SEROTYPING; STATISTICS;

CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; SEROTYPING; VACCINES, ATTENUATED; WORLD HEALTH;

EID: 84899557673     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. CDC. Progress toward eradication of polio—worldwide, January 2011– March 2013. MMWR 2013;62:335–8.
2. CDC. Update on vaccine-derived polioviruses—worldwide, April 2011– June 2012. MMWR 2012;61:741–6.
3. Global Polio Eradication Initiative. Polio eradication and endgame strategic plan (2013–2018). Geneva, Switzerland: World Health Organization, Global Polio Eradication Initiative; 2013. Available at http://www.polioeradication.org/portals/0/document/resources/strategywork/endgamestratplan_20130414_eng.pdf.
4. CDC. Tracking progress toward global polio eradication, 2010–2011. MMWR 2012;61:265–9.
5. Kilpatrick DR, Ching K, Iber J, et al. Identification of vaccine-derived polioviruses using dual-stage real-time RT-PCR. J Virol Meth 2014;197:25–8.
6. Gumede N, Lentsoane O, Burns CC, et al. Emergence of vaccine-derived polioviruses, Democratic Republic of Congo, 2004–2011. Emerg Infect Dis 2013;19:1583–9.
7. Burns C, Shaw J, Jorba J, et al. Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J Virol 2013;87:4907–22.
8. Li L, Ivanova O, Triki H, et al. Poliovirus excretion among persons with primary immune deficiency disorders: summary of a seven-country study series. J Infect Dis. In press 2014.
9. Al-Hello H, Jorba J, Blomqvist S, Raud R, Kew O, Roivainen M. Highly divergent types 2 and 3 vaccine-derived polioviruses isolated from sewage in Tallinn, Estonia. J Virol 2013;87:13076–80.
10. Oberste MS, Moore D, Anderson B, Pallansch MA, Pevear DC, Collett MS. In vitro antiviral activity of V-073 against polioviruses. Antimicrob Agents Chemother 2009;53:4501–3.